KCNA3 and Prolonged QT interval: Key results demonstrate the ILE’s superior accuracy in protein classification and virtual high-throughput screening, with a notable breakthrough in drug development for assessing drug-induced long QT syndrome risks through hERG potassium channel interaction analysis.